Optometrist · Yuba City, CA
NPI
1073090346
Since 2018
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
901 Maple Ave
Yuba City, CA, 95991
Phone (530) 674-8170
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
33,271 services
Medicare patients, 2024
1,686
Average age 74
Drug cost, 2024
$1.5M
4,079 prescriptions
Company payments, 2025
$174
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bradley Hamar was code 83861 (clinical chemistry), 11,716 times for 1,632 patients. In total Bradley Hamar billed 33,271 services in 22 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83861 Clinical Chemistry | Office | 11,716 | 1,632 | $21.90 | $257K |
| 68761 Eye | Office | 7,179 | 1,059 | $69.30 | $498K |
| 92012 Ophthalmological E&M | Office | 3,343 | 1,278 | $70.68 | $236K |
| 92134 Computerized Ophthalmic Imaging | Office | 2,362 | 1,458 | $31.20 | $74K |
| 92014 Ophthalmological E&M | Office | 1,541 | 1,073 | $91.93 | $142K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,242 | 840 | $28.63 | $36K |
| 65778 Eye | Office | 887 | 509 | $967.74 | $858K |
| 92250 Angiography | Office | 852 | 740 | $29.74 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 840 | 768 | $46.58 | $39K |
| 92283 Ophthalmological E&M | Office | 784 | 711 | $44.85 | $35K |
| 92284 Ophthalmological E&M | Office | 743 | 732 | $29.28 | $22K |
| 92020 Ophthalmological E&M | Office | 466 | 454 | $21.48 | $10K |
| 92273 Test - Miscellaneous | Office | 349 | 340 | $107.92 | $38K |
| 92025 Test - Miscellaneous | Office | 333 | 302 | $25.70 | $8,558 |
| 92004 Ophthalmological E&M | Office | 244 | 244 | $97.41 | $24K |
By year: 2022 $1.8M for 27,807 services; 2023 $2.4M for 30,774 services; 2024 $2.3M for 33,271 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 11,716 | 1,632 | $21.90 | $257K |
Medicare prescription drug claims, 2024
In 2024, the drug Bradley Hamar prescribed most often to Medicare patients was Latanoprost, with 818 prescriptions and refills. In total Bradley Hamar wrote 4,079 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 818 | 1,784 | 283 | $9,050 |
| Prednisolone Acetate Generic | 630 | 1,052 | 393 | $24K |
| Cyclosporine Generic | 392 | 778 | 174 | $179K |
| Timolol Maleate Generic | 323 | 585 | 99 | $3,496 |
| Restasis Cyclosporine | 209 | 400 | 82 | $246K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 206 | 290 | 138 | $11K |
| Dexamethasone Sodium Phosphate Generic | 189 | 305 | 120 | $9,641 |
| Lumigan Bimatoprost | 151 | 296 | 44 | $79K |
| Ofloxacin Generic | 149 | 221 | 130 | $2,386 |
| Fluorometholone Generic | 116 | 217 | 71 | $9,406 |
| Azelastine Hcl Generic | 88 | 115 | 49 | $1,974 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 87 | 175 | 25 | $1,838 |
| Brimonidine Tartrate Generic | 67 | 140 | 23 | $3,520 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 64 | 117 | 20 | $12K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 62 | 72 | 43 | $769 |
Brand drugs: 2,146 claims; generic drugs: 1,933 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bradley Hamar $174 ($174 in general payments such as food, travel and fees) from 4 companies. The largest payer was Alcon Vision LLC with $55.23.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 2 | $55.23 |
| Abbvie Inc. ABBV | 2 | $53.84 |
| Amgen Inc. AMGN | 2 | $38.57 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $26.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.